Lass, U., Hartmann, C., Capper, D., Herold-Mende, C., Deimling, A. v., Meiboom, M., & Müller, W. C. (2013). Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomas. Brain pathology, 23(3), . https://doi.org/10.1111/bpa.12003
Chicago-Zitierstil (17. Ausg.)Lass, Ulrike, Christian Hartmann, David Capper, Christel Herold-Mende, Andreas von Deimling, Maren Meiboom, und Wolf C. Müller. "Chromogenic in Situ Hybridization Is a Reliable Alternative to Fluorescence in Situ Hybridization for Diagnostic Testing of 1p and 19q Loss in Paraffin-embedded Gliomas." Brain Pathology 23, no. 3 (2013). https://doi.org/10.1111/bpa.12003.
MLA-Zitierstil (9. Ausg.)Lass, Ulrike, et al. "Chromogenic in Situ Hybridization Is a Reliable Alternative to Fluorescence in Situ Hybridization for Diagnostic Testing of 1p and 19q Loss in Paraffin-embedded Gliomas." Brain Pathology, vol. 23, no. 3, 2013, https://doi.org/10.1111/bpa.12003.